Skip to main content
Log in

The post-HAPO situation with gestational diabetes: the bright and dark sides

  • Review Article
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

Abstract

Aim

In 2010, in light of the data coming from the HAPO study, the International Association of Diabetes and Pregnancy Study Groups (IADPSG) proposed a new detection strategy and diagnostic criteria for gestational diabetes based on a one-step approach with a 75 g OGTT. This review analyzes and discusses the bright and dark sides of their application.

Methods

The assessment of these recommendations by the international organizations involved in the care of gestational diabetes and a series of observational, retrospective and prospective studies that have been published since 2010 regarding the use of the IADPSG recommendations have been evaluated.

Results

The different international associations involved in the care of pregnancy and of pregnancy complicated by diabetes have not taken an univocal position some of which have accepted them, while others have criticized them. Then, the actual application of the approach recommended by the IADPSG for detecting and diagnosing GDM varies, even at centers that reportedly accept the new diagnostic criteria.

Conclusion

So the challenge lies in making every effort to achieve a global standardization of the strategies for detecting, diagnosing and treating GDM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. American Diabetes Association (2006) Diagnosis and classification of diabetes mellitus. Diabetes Care 29(suppl 1):S43–S48

    Google Scholar 

  2. Lapolla A, Dalfrà MG, Bonomo M et al (2009) Gestational diabetes mellitus in Italy: a multicenter study. Eur J Obstet Gynecol Reprod Biol 145(2):149–153

    Article  PubMed  Google Scholar 

  3. Metzger BE, Lowe P, Dyer AR et al (2008) Hyperglycemia and adverse pregnancy outcomes. New Engl J Med 38:1991–2002

    Google Scholar 

  4. Kim C, Newton KM, Knoop RH (2002) Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes care 25:1862–1868

    Article  PubMed  Google Scholar 

  5. O’Sullivan JB, Mahan C (1964) Criteria for oral glucose tolerance test in pregnancy. Diabetes 13:436–440

    Article  Google Scholar 

  6. Sermer M, Naylor CD, Gare DJ et al (1995) Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes. Am J Obstet Gynecol 173:146–156

    Article  PubMed  CAS  Google Scholar 

  7. Jensen DM, Damm P, Sørensen B et al (2001) Clinical impact of mild carbohydrate intolerance in pregnancy: a study of 2904 nondiabetic Danish women with risk factors for gestational diabetes mellitus. Am J Obstet Gynecol 185:413–419

    Article  PubMed  CAS  Google Scholar 

  8. Vambergue A, Nuttens MC, Verier-Mine O et al (2000) Is mild gestational hyperglycaemia associated with maternal and neonatal complications? The Diagest Study. Diabet Med 17:203–208

    Article  PubMed  CAS  Google Scholar 

  9. Lapolla A, Dalfrà MG, Bonomo M et al (2007) Can plasma glucose and HbA1c predict fetal growth in mothers with different glucose tolerance levels? Diabetes Res Clin Pract 77(3):465–470

    Article  PubMed  CAS  Google Scholar 

  10. Lapolla A, Bonomo M, Dalfrà MG et al (2010) Prepregnancy BMI influences maternal and fetal outcomes in women with isolated gestational hyperglycaemia: a multicentre study. Diabetes Metab 36(4):265–270

    Article  PubMed  CAS  Google Scholar 

  11. HAPO Study Cooperative Research Group, Metzger BE, Lowe LP et al (2008) Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358:1991–2001

    Article  Google Scholar 

  12. Crowther CA, Hiller JE, Moss JR et al (2005) Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 352:2477–2486

    Article  PubMed  CAS  Google Scholar 

  13. Landon MB, Spong CY, Thom E et al (2009) A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 361:1339–1348

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  14. Schmidt MI, Duncan BB, Reichelt AJ et al (2001) gestational diabetes mellitus diagnosed with 75 gr glucose tolerance test and adverse pregnancy outcome. Diabetes Care 24:1151–1115

    Article  PubMed  CAS  Google Scholar 

  15. International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33:676–682

    Article  PubMed Central  CAS  Google Scholar 

  16. Committee Opinion Number 504, American College of Obstetricians and Gynecologists (2011) Screening and diagnosis of gestational diabetes mellitus. Obstet Gynecol 118:751–753

    Article  Google Scholar 

  17. Ryan EA (2011) Diagnosis of gestational diabetes. Diabetologia 54:480–486

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Long H (2011) Diagnosis of gestational diabetes: can expert opinion replace scientific evidence? Diabetologia 54:2211–2213

    Article  PubMed  CAS  Google Scholar 

  19. Long H, Cundy T (2013) Establishing consensus in the diagnosis of gestational diabetes following HAPO: were do we stand? Curr Diab Res 13:43–50

    Article  Google Scholar 

  20. McIntire HD, Metzger BE, Coustan DR et al (2014) Counterpoint: establishing consensus in the diagnosis of gestational diabetes following the HAPO study. Curr Diab Res 14:497–454

    Article  Google Scholar 

  21. Sacks DA, Hadden DR, Deerochanawong C et al (2012) Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study. Diabetes Care 35:526–528

    Article  PubMed  PubMed Central  Google Scholar 

  22. Duran A, Saenz S, Torrejon MJ et al (2014) Introduction of IADPSG criteria for the screening and diagnosis of gestational diabetes mellitus results in improved pregnancy outcomes at a lower cost in a large cohort of pregnancy woman: the St. Carlos Gestational Diabetes Study. Diabetes Care 37:2442–2450

    Article  PubMed  Google Scholar 

  23. Lapolla A, Dalfrà MG, Ragazzi E et al (2011) New International Association of the Diabetes and Pregnancy Study Groups (IADPSG) recommendations for diagnosing gestational diabetes compared with former criteria: a retrospective study on pregnancy outcome. Diabet Med 28(9):1074–1077

    Article  PubMed  CAS  Google Scholar 

  24. Wery E, Vambergue A, Le Goueff F et al (2014) Impact of the new screening criteria on the gestational diabetes prevalence. J Gynecol Obstet Biol Reprod 43(4):307–313

    Article  CAS  Google Scholar 

  25. Mayo K, Melamed N, Vandenberghe H et al (2105) The impact of adoption of the international association of diabetes in pregnancy study group criteria for the screening and diagnosis of gestational diabetes. Am J Obstet Gynecol 212(2):224–228

    Google Scholar 

  26. Kong JM, Lim K, Thompson DM (2015) Evaluation of the International Association of the Diabetes In Pregnancy Study Group new criteria: gestational diabetes project. Can J Diabetes 39(2):128–132

    Article  PubMed  Google Scholar 

  27. Feldman RK, Tieu RS, Yasumura L (2016) Gestational diabetes screening: the international association of the diabetes and pregnancy study groups compared with Carpenter–Coustan screening. Obstet Gynecol 127(1):10–17

    Article  Google Scholar 

  28. Ogunleye OK, Davidson KD, Gregg AR, Egerman RS (2017) Perinatal outcomes after adopting 1- versus 2-step approach to diagnosing gestational diabetes. J Matern Fetal Neonatal Med 30(2):186–190

    Article  PubMed  CAS  Google Scholar 

  29. Avalos GE, Owens LA, Dunne F, ATLANTIC DIP Collaborators (2013) Applying current screening tools for gestational diabetes mellitus to a European population: is it time for change? Diabetes Care 36(10):3040–3044

    Article  PubMed  PubMed Central  Google Scholar 

  30. Donovan LE, Edwards AL, Savu A et al (2017) Population-level Outcomes with a 2-step approach for gestational diabetes screening and diagnosis. Can J Diabetes. https://doi.org/10.1016/j.jcjd.2016.12.010

    Article  PubMed  Google Scholar 

  31. Sacks DA, Black MH, Li X, Montoro MN, Lawrence JM (2016) Adverse pregnancy outcomes using the international association of the diabetes and pregnancy study groups criteria: glycemic thresholds and associated risks. Obstet Gynecol 126(1):67–73

    Article  Google Scholar 

  32. Waters TP, Dyer AR, Scholtens DM et al (2016) Maternal and neonatal morbidity for woman who would be added to the diagnosis of GDM using IADPSG criteria: a secondary analysis of the hyperglycemia and adverse pregnancy outcome study. Diabetes Care 39:2204–2210

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  33. Mission JF, Ohno MS, Cheng YW, Caughey AB (2012) Gestational diabetes screening with the new IADPSG guidelines: a cost-effectiveness analysis. Am J Obstet Gynecol 207:326.e1–326.e9

    Article  Google Scholar 

  34. Werner EF, Pettker CM, Zuckerwise L et al (2012) Screening for gestational diabetes mellitus: are the criteria proposed by the international association of the Diabetes and Pregnancy Study Groups cost-effective? Diabetes Care 35(3):529–535

    Article  Google Scholar 

  35. Marseille E, Lohse N, Jiwani A et al (2013) The cost-effectiveness of gestational diabetes screening including prevention of type 2 diabetes: application of a new model in India and Israel. J Matern Fetal Neonatal Med 26(8):802–810

    Article  PubMed  Google Scholar 

  36. Moses RG, Morris GJ, Petocz P, SanGil F (2011) The impact of potential new diagnostic criteria on the prevalence of gestational diabetes mellitus in Australia. Med J Aust 194(7):338–340

    PubMed  Google Scholar 

  37. Agarwal MM, Dhatt GS, Othman Y (2015) Gestational diabetes: differences between the current international diagnostic criteria and implications of switching to IADPSG. J Diabetes Compl 29(4):544–549

    Article  CAS  Google Scholar 

  38. Kalter-Leibovici O, Freedman LS, Olmer L, Lieberman N, Heymann A, Orna T, Lerner-Geva L, Hod M (2012) Screening and diagnosis of gestational diabetes mellitus. Diabetes Care 35:1894–1896

    Article  PubMed  PubMed Central  Google Scholar 

  39. Savona-Ventura C, Vassallo J, Marre M, Karamanos BG; MGSD-GDM study group (2013) A composite risk assessment model to screen for gestational diabetes mellitus among Mediterranean women. Int J Gynaecol Obstet 120(3):240–244

    Article  PubMed  Google Scholar 

  40. Yeral MI, Ozgu-Erdinc AS, Uygur D et al (2014) Prediction of gestational diabetes mellitus in the first trimester, comparison of fasting plasma glucose, two-step and one-step methods: a prospective randomized controlled trial. Endocrine 46(3):512–518

    Article  PubMed  CAS  Google Scholar 

  41. Poomalar GK, Rangaswamy V (2013) A comparison of fasting plasma glucose and glucose challenge test for screening of gestational diabetes mellitus. J Obstet Gynaecol 33(5):447–450

    Article  PubMed  CAS  Google Scholar 

  42. Ozgu-Erdinc AS, Yilmaz S, Yeral MI et al (2015) Prediction of gestational diabetes mellitus in the first trimester: comparison of C-reactive protein, fasting plasma glucose, insulin and insulin sensitivity indices. J Matern Fetal Neonatal Med 28(16):1957–1962

    Article  PubMed  CAS  Google Scholar 

  43. Wang C, Zhu W, Wei Y et al (2016) The predictive effects of early pregnancy lipid profiles and fasting glucose on the risk of gestational diabetes mellitus stratified by body mass index. J Diabetes Res 2016:3013357

    Google Scholar 

  44. Agarwal MM (2016) Gestational diabetes mellitus: screening with fasting plasma glucose. World J Diabetes 7:279–289

    Article  PubMed  PubMed Central  Google Scholar 

  45. Agarwal MM, Dhatt GS, Punnose J, Zayed R (2007) Gestational diabetes: fasting and postprandial glucose as first prenatal screening tests in a high-risk population. J Reprod Med 52(4):299–305

    PubMed  CAS  Google Scholar 

  46. Corrado F, D’Anna R, Cannata ML et al (2012) Correspondence between first-trimester fasting glycaemia, and oral glucose tolerance test in gestational diabetes diagnosis. Diabetes Metab 38(5):458–461

    Article  PubMed  CAS  Google Scholar 

  47. Riskin-Mashiah S, Damti A, Younes G, Auslender R (2010) First trimester fasting hyperglycemia as a predictor for the development of gestational diabetes mellitus. Eur J Obstet Gynecol Reprod Biol 152(2):163–167

    Article  PubMed  CAS  Google Scholar 

  48. Zhu WW, Yang HX, Wei YM et al (2013) Evaluation of the value of fasting plasma glucose in the first prenatal visit to diagnose gestational diabetes mellitus in China. Diabetes Care 36(3):586–590

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  49. Popova P, Tkachuk A, Dronova A et al (2016) Fasting glycemia at the first prenatal visit and pregnancy outcomes in Russian women. Minerva Endocrinol 41(4):477–485

    PubMed  Google Scholar 

  50. Jiwani A, Marseille E, Lohse N et al (2012) Gestational diabetes mellitus: results from a survey of country prevalence and practices. J Matern Fetal Neonatal Med 25:600–610

    Article  PubMed  Google Scholar 

  51. Buckley BS, Harreiter J, Damm P et al (2012) Gestational diabetes mellitus in Europe: prevalence, current screening practice and barriers to screening. A review. Diabet Med 29:844–854

    Article  PubMed  CAS  Google Scholar 

  52. Pintaudi B, Fresa R, Dalfrà M et al (2016) Level of implementation of guidelines on screening and diagnosis of gestational diabetes: a national survey. Diabetes Res Clin Pract 113:48–52

    Article  PubMed  Google Scholar 

  53. WHO (2013) Diagnostic criteria and classification of hyperglycemia first detected in pregnancy. World Health Organization, Geneva

    Google Scholar 

  54. ACOG (2011) Committee opinion no. 504: screening and diagnosis of gestational diabetes mellitus. Obstet Gynecol 18(3):751–753

    Google Scholar 

  55. Benhalima K, Van Crombrugge P, Devlieger R et al (2013) Screening for pregestational and gestational diabetes in pregnancy: a survey of obstetrical centers in the northern part of Belgium. Diabetol Metab Syndr 5:66–70

    Article  PubMed  PubMed Central  Google Scholar 

  56. American Diabetes Association (2017) Standard of medical care in diabetes. Gestational diabetes mellitus. Diabetes Care 40(1):S11–S24

    Article  Google Scholar 

  57. NICE Guidelines (2015) Diabetes in pregnancy: management from preconception to the postnatal period. https://www.nice.org.uk/guidance.ng3

  58. Di CianniG, Gualdani E, Berni C, Meucci A, Roti L, Lencioni C, Lacaria E, Seghieri G, Francesconi P (2017) Screening for gestational diabetes in Tuscany, Italy. A population study. Diab Res Clin pract 132:149–156

    Article  Google Scholar 

  59. Nielsen KK, De Courten M, Kapur A (2012) The urgent need for universally applicable simple screening procedures and diagnostic criteria for gestational diabetes mellitus-lessons from projects funded by the World Diabetes Foundation. Global Health Action 5:1–12

    Article  Google Scholar 

  60. Agarwal MM, Shah SM, Al Kaabi J, Saquib S, Othman Y (2015) Gestational diabetes mellitus: Confusion among medical doctors caused by multiple international criteria. J Obstet Gynaecol Res 41(6):861–869

    Article  PubMed  Google Scholar 

  61. Hod M, Kapur A, Sacks DA et al (2015) The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: A pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet 131(Suppl 3):S173–S211

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Annunziata Lapolla.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Ethical approval

This article does not contain any studies with human participants performed by any of the authors.

Informed consent

For this type of study formal consent is not required.

Additional information

Managed by Massimo Federici.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lapolla, A., Metzger, B.E. The post-HAPO situation with gestational diabetes: the bright and dark sides. Acta Diabetol 55, 885–892 (2018). https://doi.org/10.1007/s00592-018-1146-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-018-1146-7

Keywords

Navigation